home.social

#mpox — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #mpox, aggregated by home.social.

  1. "The Centers for Disease Control and Prevention, under Trump Health and Human Services Secretary Robert F. Kennedy Jr., has quietly removed a federal public health webpage offering explicit safer-sex and harm reduction guidance for mpox. The deletion confirms fears among LGBTQ+ health experts that the Trump administration is once again illegally scrubbing medically vetted information tied to queer communities from government websites."

    #mpox #CDC #Pride #LGBTQ
    advocate.com/health/sexual-hea

  2. Podcast about Mpox in Melbourne and new Australian research about trans and gender diverse people living with HIV. Interview with Living Positive Victoria CEO Richard Keane. #health #lgbtiqa #lgbtq #research #mpox @3CRMelbourne
    3cr.org.au/inyaface/episode/mp

  3. Podcast about Mpox in Melbourne and new Australian research about trans and gender diverse people living with HIV. Interview with Living Positive Victoria CEO Richard Keane. #health #lgbtiqa #lgbtq #research #mpox @3CRMelbourne
    3cr.org.au/inyaface/episode/mp

  4. Podcast about Mpox in Melbourne and new Australian research about trans and gender diverse people living with HIV. Interview with Living Positive Victoria CEO Richard Keane. #health #lgbtiqa #lgbtq #research #mpox @3CRMelbourne
    3cr.org.au/inyaface/episode/mp

  5. Podcast about Mpox in Melbourne and new Australian research about trans and gender diverse people living with HIV. Interview with Living Positive Victoria CEO Richard Keane. #health #lgbtiqa #lgbtq #research #mpox @3CRMelbourne
    3cr.org.au/inyaface/episode/mp

  6. Podcast about Mpox in Melbourne and new Australian research about trans and gender diverse people living with HIV. Interview with Living Positive Victoria CEO Richard Keane. #health #lgbtiqa #lgbtq #research #mpox @3CRMelbourne
    3cr.org.au/inyaface/episode/mp

  7. NanoViricides to initiate Phase II trial of NV-387 for MPox treatment in DRC starting April 2026, advancing its broad-spectrum antiviral program. #Biotech #MPox

  8. NanoViricides to initiate Phase II trial of NV-387 for MPox treatment in DRC starting April 2026, advancing its broad-spectrum antiviral program. #Biotech #MPox

  9. NanoViricides to initiate Phase II trial of NV-387 for MPox treatment in DRC starting April 2026, advancing its broad-spectrum antiviral program. #Biotech #MPox

  10. NanoViricides to initiate Phase II trial of NV-387 for MPox treatment in DRC starting April 2026, advancing its broad-spectrum antiviral program. #Biotech #MPox

  11. NanoViricides to initiate Phase II trial of NV-387 for MPox treatment in DRC starting April 2026, advancing its broad-spectrum antiviral program. #Biotech #MPox